MedTrace Logo

Study of Exercise to Manage Distress During Breast Screening

NCT02468050 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-06-10

No results posted yet for this study

Summary

The breast cancer screening and diagnostic period is associated with heightened symptoms of anxiety and depression. Physical exercise has been found to effectively decrease these symptoms in healthy and diseased populations. This study aims to determine if a pre treatment exercise intervention can minimize symptoms of anxiety and depression in women undergoing screening for breast cancer.

Conditions

Interventions

BEHAVIORAL

Moderate intensity exercise training

6 weeks of moderate intensity exercise training (50 - 75% of heart rate reserve). Sessions are facility and home based and include cardiovascular warm-up, cardiovascular training, muscular conditioning, and flexibility exercises.

BEHAVIORAL

Self Management of exercise

In addition to the 6 week exercise program (refer to Exercise Treatment Group), participants randomly assigned to the Self Management Group will learn strategies for the self management of exercise.

Sponsors & Collaborators

  • University of Western Ontario, Canada

    lead OTHER

Principal Investigators

  • Muriel Brackstone, MD PhD FRCSC · London Regional Cancer Program

  • Anita G Cramp, PhD · Western University

  • Amy Kossert, MHK · Western University

  • Harry Prapavessis, PhD · Western University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468050 on ClinicalTrials.gov